I have been missing many things here at the MSM Monitor. All I can do is apologize and thank you for sticking with me.
"Surge in federal approvals buoys drug makers" by Robert Weisman | Globe Staff, January 08, 2013
SAN FRANCISCO — Something odd is going on in the pharmaceutical world: Though the industry is coping with a sluggish economy and bracing for federal cuts in medical research funding, the mood among the 8,000 executives at the industry’s premier investors conference, the 31st annual J.P. Morgan Healthcare Conference, is decidedly upbeat....
Related:
Sequestration Scare Continues
Sunday Globe Specials: Defending Sequestration
The Mendacious Obama Administration
They know something you don't?
But even with the rash of innovation, drug makers and other life science companies know it is not enough to make a great medicine or diagnostic device these days. They must work extra hard in a stubbornly weak economy to show commercial and government payers that their products not only meet unmet medical needs, but can save the health care system money....
Tran$lation: You will receive rationed care and cuts in services in exchange for growing corporate profits.
Here's to your health, readers!
Boston consultant Jonathan P. Gertler, cofounder and senior partner at Back Bay Life Science Advisors: “I think it’s going to be another good year for biotech and pharmaceutical companies.”
Me, too. Don't you know we are in the age of golden profits, or something like that?
--more--"
Related:
Children’s Hospital to help form diagnostics company
Cambridge cancer diagnosticians strike a chord
For Mass. drug firms, Calif. event is a must
Drug companies again taking medical clients out for meals
Also see: Poison For Profit
The Health Care Conferences You Never Heard About
Economy Showing Signs of Life
I did attend in past years.
